Skip to main content
Figure 3 | Molecular Pain

Figure 3

From: Familial hemiplegic migraine CaV2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain

Figure 3

Ca2+ transients evoked by K+ depolarization or P2X 3 receptors in WT and R192Q KI neurons. A, Examples of Ca2+ transients of trigeminal neurons evoked by KCl (20 mM, 2-s application) before (black trace) and after (red trace) application of ω-agatoxin (200 nM, 30 min). B, KI neurons show significant increase in KCl (20 mM, 2-s application) mediated Ca2+ transients compared to WT (*p = 0.005, n = 28 and n = 45, in WT and KI, respectively). Histograms also represent inhibition by ω-agatoxin of Ca2+ transients for WT (n = 14) and KI (n = 35) neurons. After ω-agatoxin responses of WT and KI neurons differ from their own controls (**p ≤ 0.001). C, Representative traces of α,β-meATP (10 μ M, 2-s application)-evoked Ca2+ transients before (black trace) and after (red trace) application of ω-agatoxin (200 nM, 30 min). D, Histograms show larger Ca2+ transients evoked by α,β-meATP (10 μ M, 2-s application) from KI (n = 26) than WT (n = 16) and neurons (*p = 0.04). Histograms also show that ω-agatoxin reduced Ca2+ transients of KI (n = 22) and WT (n = 9) neurons. **p ≤ 0.001 for each case. E, Microphotographs of immunofluorescence experiments depicting WT and KI trigeminal neurons in culture expressing P2X3 receptors or CaV2.1 channels. Bar = 50 μ m. Histograms (right) show% of P2X3- (top) or CaV2.1- (bottom) immunoreactive neurons (taking as 100% the β-tubulin III immunoreactive) (n = 5, p > 0.05 for P2X3 receptors; n = 3, p > 0.05 for CaV2.1-expressing neurons). F, Histograms show% of CaV2.1-immunoreactive neurons (top; taken as 100%) which are immunopositive for P2X3 (n = 7, p > 0.05) or% of P2X3-immunoreactive neurons (bottom) which are immunopositive for CaV2.1 (n = 4, p > 0.05).

Back to article page